The Cancer Cell Therapy Showdown: CAR-Ts Versus CAR-NKs

 
• By Ayisha Sharma

Will CAR-NK cell therapies overshadow traditional CAR-T options for the treatment of some cancers? While preliminary data for CAR-NKs point to enhanced safety and solid tumor penetration, oncologists and executives discuss the pros and cons of these two approaches to cell therapy. 

3D illustration of T cells attacking a cancer cell (CAR-T cell therapy) - Illustration
CAR T-Cell Therapy

More from Business Strategy

More from In Vivo